Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00511537 · ClinicalTrials.gov registry record
Unrelated Stem Cell Transplantation for Adults With Hematopoietic Disorders
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 30
- Enrollment target
NCT00511537: Completed study, sponsored by University of California, San Francisco.
NCT00511537 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00511537 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This study performs HLA matched stem cell transplantation from unrelated donors in adults who require stem cell transplantation but do not have a matched related donor available. The incidence of graft-versus-host disease in unrelated stem cell transplantation is recorded. This study also monitors the activity and toxicity of total body irradiation and cyclosphosphamide followed by stem cell transplantation from matched unrelated donors.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 1999-01 |
| Est. Completion | 2009-06 |
What the finished NCT00511537 record still lists
NCT00511537 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00511537 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00511537 about?
NCT00511537 is a clinical study titled "Unrelated Stem Cell Transplantation for Adults With Hematopoietic Disorders". This study performs HLA matched stem cell transplantation from unrelated donors in adults who require stem cell transplantation but do not have a matched related donor available. The incidence of graft-versus-host disease in unrelated stem cell transplantation is recorded. This study also monitors t...
What is the current status of trial NCT00511537?
This trial is currently completed. The enrollment target is 30 participants. The study started on 1999-01. Estimated completion is 2009-06.
Who is sponsoring clinical trial NCT00511537?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia